(Q33504341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

1 reference

1 reference

1 reference

cervix uterine cancer

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

G Zanetta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Lissoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

C Sessa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

N Colombo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

D Gueli-Alletti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

C Mangioni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

977-980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

A possible new trend in the management of the carcinoma of the cervix uteri

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Factors predicting response to chemotherapy and survival in patients with metastatic or recurrent squamous cell cervical carcinoma: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Ifosfamide with mesna in squamous carcinoma of the cervix: Phase II results in patients with advanced or recurrent disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Bleomycin, ifosfamide and cis-platin chemotherapy in recurrent and persistent cervical cancer, a prospective study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB–IIB Invasive Cervical Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008461408626

7 January 2021

Identifiers

DOI

10.1023/A:1008461408626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9818071%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference